{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:46:22Z","timestamp":1772509582450,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","geriatric.theclinics.com","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cger.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T15:02:36Z","timestamp":1507993356000},"page":"131-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Vaccinations in Older Adults"],"prefix":"10.1016","volume":"34","author":[{"given":"Megan","family":"Burke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.cger.2017.08.006_bib1","first-page":"1","article-title":"A\u00a0pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011","volume":"127","author":"National Vaccine Advisory Committee","year":"2012","journal-title":"Public Health Rep"},{"key":"10.1016\/j.cger.2017.08.006_bib2","unstructured":"Healthy people 2020. Available at: https:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases. Accessed May 17, 2017."},{"issue":"3","key":"10.1016\/j.cger.2017.08.006_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cger.2007.03.005","article-title":"Host resistance and immune responses in advanced age","volume":"23","author":"Castle","year":"2007","journal-title":"Clin Geriatr Med"},{"issue":"11","key":"10.1016\/j.cger.2017.08.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2015","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.cger.2017.08.006_bib5","unstructured":"Rolfes MA, Foppa IM, Garg S, et\u00a0al. Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. 2016; Available at: https:\/\/www.cdc.gov\/flu\/about\/disease\/2015-16.htm. Accessed May 17, 2017."},{"issue":"5","key":"10.1016\/j.cger.2017.08.006_bib6","first-page":"136","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older\u2014United States, 2017","volume":"66","author":"Kim","year":"2017","journal-title":"MMWR Surveill Summ"},{"issue":"6","key":"10.1016\/j.cger.2017.08.006_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/cid\/cit404","article-title":"Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season","volume":"57","author":"Kwong","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.cger.2017.08.006_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/infdis\/jiq076","article-title":"Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults","volume":"203","author":"Talbot","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.cger.2017.08.006_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.cger.2017.08.006_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001269.pub4","article-title":"Vaccines for preventing influenza in the elderly","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.cger.2017.08.006_bib11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S1473-3099(14)70960-0","article-title":"Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies","volume":"14","author":"Darvishian","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.cger.2017.08.006_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004876.pub2","article-title":"Vaccines for preventing influenza in the elderly","author":"Rivetti","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cger.2017.08.006_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older","volume":"200","author":"Falsey","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.cger.2017.08.006_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.cger.2017.08.006_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/cid\/civ261","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans","volume":"61","author":"Richardson","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.cger.2017.08.006_bib16","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.vaccine.2017.03.092","article-title":"Efficacy and safety of high-dose influenza vaccine in elderly adults: a systematic review and meta-analysis","volume":"35","author":"Wilkinson","year":"2017","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.cger.2017.08.006_bib17","first-page":"485","article-title":"Licensure of a high-dose inactivated influenza vaccine for persons aged\u00a0>or=65 years (Fluzone High-Dose) and guidance for use\u2014United States, 2010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"10.1016\/j.cger.2017.08.006_bib18","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2011.02.088","article-title":"Healthcare utilization and cost of pneumococcal disease in the United States","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.cger.2017.08.006_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vaccine.2015.11.048","article-title":"Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands","volume":"34","author":"Wagenvoort","year":"2016","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.cger.2017.08.006_bib20","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/infdis\/jis240","article-title":"Aging population and future burden of pneumococcal pneumonia in the United States","volume":"205","author":"Wroe","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"37","key":"10.1016\/j.cger.2017.08.006_bib21","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged\u00a0>\/=65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cger.2017.08.006_bib22","series-title":"Epidemology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2015"},{"issue":"18","key":"10.1016\/j.cger.2017.08.006_bib23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults","volume":"348","author":"Jackson","year":"2003","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.cger.2017.08.006_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000422.pub3","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cger.2017.08.006_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: a meta-analysis","volume":"180","author":"Huss","year":"2009","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.cger.2017.08.006_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","article-title":"Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study","volume":"17","author":"Suzuki","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.cger.2017.08.006_bib27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A\u00a0trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.cger.2017.08.006_bib28","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cger.2017.08.006_bib29","series-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u2265 65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)","first-page":"279","article-title":"Epidemiology and prevention of\u00a0vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.cger.2017.08.006_bib30","unstructured":"NHS. Pneumococcal vaccine. 2016. Available at: http:\/\/www.nhs.uk\/Conditions\/vaccinations\/Pages\/pneumococcal-vaccination.aspx. Accessed October 5, 2017."},{"issue":"9","key":"10.1016\/j.cger.2017.08.006_bib31","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.cger.2017.08.006_bib32","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1086\/605611","article-title":"Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine","volume":"200","author":"Weinberg","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.cger.2017.08.006_bib33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.cger.2017.08.006_bib34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"New Engl J Med"},{"issue":"33","key":"10.1016\/j.cger.2017.08.006_bib35","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"10.1016\/j.cger.2017.08.006_bib36","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A\u00a0vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.cger.2017.08.006_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cger.2017.08.006_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008858.pub3","article-title":"Vaccines for preventing herpes zoster in older adults","author":"Gagliardi","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.cger.2017.08.006_bib39","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.cger.2017.08.006_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/infdis\/jit182","article-title":"Safety of zoster vaccine in elderly adults following documented herpes zoster","volume":"208","author":"Morrison","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"RR-5","key":"10.1016\/j.cger.2017.08.006_bib41","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recommendations Rep"},{"issue":"12","key":"10.1016\/j.cger.2017.08.006_bib42","first-page":"365","article-title":"Tetanus surveillance\u2014United States, 2001-2008","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.cger.2017.08.006_bib43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM199503233321201","article-title":"A\u00a0population-based serologic survey of immunity to tetanus in the United States","volume":"332","author":"Gergen","year":"1995","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.cger.2017.08.006_bib44","first-page":"39","article-title":"Influenza, pneumococcal, and tetanus toxioid vaccination of adults\u2013United States, 1993-7","volume":"49","author":"Singleton","year":"2000","journal-title":"MMWR CDC Surveill Summ"},{"issue":"9","key":"10.1016\/j.cger.2017.08.006_bib45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-136-9-200205070-00008","article-title":"Serologic immunity to diphtheria and tetanus in the United States","volume":"136","author":"McQuillan","year":"2002","journal-title":"Ann Intern Med"},{"issue":"RR-17","key":"10.1016\/j.cger.2017.08.006_bib46","first-page":"1","volume":"55","author":"Kretsinger","year":"2006","journal-title":"MMWR Recommendations Rep"},{"key":"10.1016\/j.cger.2017.08.006_bib47","unstructured":"Aging NCo. Vaccines: what Medicare pays for. 2016; Available at: https:\/\/www.ncoa.org\/wp-content\/uploads\/medicare-vaccines.pdf. Accessed May 23, 2017."},{"issue":"3","key":"10.1016\/j.cger.2017.08.006_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/M13-2332","article-title":"U.S. physicians' perspective of adult vaccine delivery","volume":"160","author":"Hurley","year":"2014","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.cger.2017.08.006_bib49","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the use of herpes zoster vaccine","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.cger.2017.08.006_bib50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.vaccine.2016.12.007","article-title":"Primary care physicians' perspective on financial issues and adult immunization in the era of the Affordable Care Act","volume":"35","author":"Hurley","year":"2017","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.cger.2017.08.006_bib51","first-page":"352","article-title":"Benefits from immunization during the vaccines for children program era\u2014United States, 1994-2013","volume":"63","author":"Whitney","year":"2014","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"issue":"2","key":"10.1016\/j.cger.2017.08.006_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amepre.2006.03.021","article-title":"Immunization disparities in older Americans: determinants and future research needs","volume":"31","author":"O'Malley","year":"2006","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.cger.2017.08.006_bib53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/1471-2458-13-388","article-title":"Social determinants of health and seasonal influenza vaccination in adults\u00a0>\/=65 years: a systematic review of qualitative and quantitative data","volume":"13","author":"Nagata","year":"2013","journal-title":"BMC Public Health"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069017300794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069017300794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T17:58:23Z","timestamp":1570211903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069017300794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0749069017300794"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2017.08.006","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccinations in Older Adults","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}